中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共9条，第1-9条

帮助

条数/页：排序方式：
	PEG-Bottlebrush Stabilizer-Based Worm-like Nanocrystal Micelles with Long-Circulating and Controlled Release for Delivery of a BCR-ABL Inhibitor against Chronic Myeloid Leukemia (CML) 期刊论文 OAI收割 PHARMACEUTICS, 2022, 卷号: 14 作者: Liang, Huamin; Zou, Fengming; Fu, Liyi \| 收藏 \| 浏览/下载：40/0 \| 提交时间：2022/12/23 drug nanocrystal stabilizer micelle BCR-ABL chronic myeloid leukemia (CML)
	Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文 OAI收割 EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897 作者: Lu, Tingting; Cao, Jiangyan; Zou, Fengming; Li, Xixiang; Wang, Aoli \| 收藏 \| 浏览/下载：62/0 \| 提交时间：2021/04/26 BCR-ABL ABL mutants Chronic myeloid leukemia Kinase inhibitor Imatinib resistance
	Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies 期刊论文 OAI收割 EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021 作者: Wang, Zeng; Jiang, Liyu; Yan, Hao; Xu, Zhifei; Luo, Peihua \| 收藏 \| 浏览/下载：51/0 \| 提交时间：2021/04/26 Adverse events chronic myeloid leukemia management mechanisms molecular target nilotinib
	An ultra-long circulating nanoparticle for reviving a highly selective BCR-ABL inhibitor in long-term effective and safe treatment of chronic myeloid leukemia 期刊论文 OAI收割 NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 卷号: 29 作者: Fu, Liyi; Zou, Fengming; Liu, Qingwang; Wang, Beilei; Wang, Junqing \| 收藏 \| 浏览/下载：56/0 \| 提交时间：2020/11/30 Chronic myeloid leukemia BCR-ABL Long-circulating nanoparticle Drug delivery
	Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文 OAI收割 CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885 作者: Wu, Jiaxin; Wang, Aoli; Li, Xixiang; Chen, Cheng; Qi, Ziping \| 收藏 \| 浏览/下载：88/0 \| 提交时间：2019/11/27 BCR-ABL PDGFR chronic myeloid leukemia kinase inhibitor
	Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia 期刊论文 OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 43, 页码: 69945-69960 作者: Zhang, Xin; Jia, Deyong; Ao, Junping; Liu, Huijuan; Zang, Yi \| 收藏 \| 浏览/下载：33/0 \| 提交时间：2019/01/08 Bisindolylmaleimide IX BCR-ABL chronic myeloid leukemia (CML)
	Simultaneous inhibition of Vps34 kinase would enhance PI3K delta inhibitor cytotoxicity in the B-cell malignancies 期刊论文 OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 33, 页码: 53515-53525 作者: Liu, Xiaochuan; Wang, Aoli; Liang, Xiaofei; Liu, Juanjuan; Zou, Fengming 收藏 \| 浏览/下载：48/0 \| 提交时间：2017/11/21 Pi3k Delta Vps34 Combination Chronic Lymphatic Leukemia Acute Myeloid Leukemia
	Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML) 期刊论文 OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 29, 页码: 45562-45574 作者: Liu, Feiyang; Wang, Beilei; Wang, Qiang; Qi, Ziping; Chen, Cheng 收藏 \| 浏览/下载：49/0 \| 提交时间：2017/11/21 Bcr-abl Pdgfr Chronic Myeloid Leukemia Kinase Inhibitor
	Antitumor effects of cucurmosin in human chronic myeloid leukemia occur through cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis 期刊论文 OAI收割 African Journal of Pharmacy and Pharmacology, 2011, 卷号: 5, 期号: 7, 页码: 985-992 J. M. Xie; W. Z. Que; M. H. Chen; J. C. Sun; T. B. Liu; H. L. Liu; M. Liu; A. Q. Yang; P. Yang; Y. L. Wang 收藏 \| 浏览/下载：54/0 \| 提交时间：2012/06/06 Cucurmosin chronic myeloid leukemia k562 cells apoptosis ribosome-inactivating protein cucurbita-moschata oxidative stress cancer cells degradation activation sarcocarp pathway acid